← ANALYSTS · TIPRANKS
Carl Byrnes · Northland Securities
Hits
37%
132 of 360 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
−4.0%
Over a year after the rating, TipRanks’ measure
Our companies rated now
9
Buy / hold / sell: 9 / 0 / 0
Upside of the analyst’s targets
+281.4%
Average over 9 current targets, to the last price
The market’s answer to the ratings
+1.5%
Day-0 move against SPY in the rating’s direction, average over 2 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Apr 24on TipRanks 09:07 | CNTBIWMConnect Biopharma Holdings · $57M | Reiterated | Buy | $7.50 | +727.8% | −0.8%next day −3.0% · 5 days −2.9% | ↗ |
| Apr 17on TipRanks 09:20 | MDXGIWMMiMedx Group · $682M | Reiterated | Buy | $10.00 → $6.00−40.0% | +35.4% | −1.6%next day −4.6% · 5 days −0.1% | ↗ |
| Apr 15on TipRanks 10:25 | SPRYIWMARS Pharmaceuticals · $405M | Reiterated | Buy | $25.00 | +521.9% | −2.3%next day +1.7% · 5 days +3.1% | ↗ |
| Mar 26on TipRanks 10:25 | RCELAvita Medical · $413M | Reiterated | Buy | $10.00 | −23.3% | −1.5%next day +0.7% · 5 days −5.5% | ↗ |
| Mar 24on TipRanks 08:35 | BLFSBioLife Solutions · $1.9B | Reiterated | Buy | $34.00 | −11.9% | +3.1%next day +0.3% · 5 days −2.7% | ↗ |
| Mar 23on TipRanks 09:20 | TLSIIWMTriSalus Life Sciences · $240M | Assigned | Buy | $12.50 → $8.00−36.0% | +120.4% | −1.3%next day −0.4% · 5 days −1.8% | ↗ |
| Feb 27on TipRanks 12:25 | INDVIWMIndivior · $4.0B | Reiterated | Buy | $50.00 | +54.1% | −2.5%next day −2.3% · 5 days +0.6% | ↗ |
| Nov 14on TipRanks 13:10 | ALVOAlvotech · $2.3B | Reiterated | Buy | $10.00 | +100.0% | −0.5%next day −5.4% · 5 days −4.5% | ↗ |
| Nov 5on TipRanks 10:05 | HRTXIWMHeron Therapeutics · $69M | Reiterated | Buy | $4.00 | +1,008.0% | −3.0%next day +0.2% · 5 days −0.9% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗